Cargando…
Cell sheet formation enhances the therapeutic effects of human umbilical cord mesenchymal stem cells on myocardial infarction as a bioactive material
Stem cell-based therapy has been used to treat ischaemic heart diseases for two decades. However, optimal cell types and transplantation methods remain unclear. This study evaluated the therapeutic effects of human umbilical cord mesenchymal stem cell (hUCMSC) sheet on myocardial infarction (MI). ME...
Autores principales: | Guo, Rui, Wan, Feng, Morimatsu, Masatoshi, Xu, Qing, Feng, Tian, Yang, Hang, Gong, Yichen, Ma, Shuhong, Chang, Yun, Zhang, Siyao, Jiang, Youxu, Wang, Heqing, Chang, Dehua, Zhang, Hongjia, Ling, Yunpeng, Lan, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941025/ https://www.ncbi.nlm.nih.gov/pubmed/33732969 http://dx.doi.org/10.1016/j.bioactmat.2021.01.036 |
Ejemplares similares
-
Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction
por: Guo, Rui, et al.
Publicado: (2020) -
Manufacture and Quality Control of Human Umbilical Cord-Derived Mesenchymal Stem Cell Sheets for Clinical Use
por: Wang, Juan, et al.
Publicado: (2022) -
Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue
por: Gao, Shuang, et al.
Publicado: (2022) -
Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes
por: Jiang, Youxu, et al.
Publicado: (2022) -
hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)